Dublin-based Endo International has made an unsolicited bid to acquire Salix Pharmaceuticals for about US$11 billion.
AbbVie, which terminated its deal to purchase Shire last year, has agreed to acquire Pharmacyclics for US$21 billion.
Mercer has acquired a 9.9% stake in Benefitfocus, a U.S. provider of cloud-based benefits software solutions, for US$74.7 million.
After failing to buy Allergan, Canada's Valeant Pharmaceuticals International has agreed to purchase Salix Pharmaceuticals for US$14.5 billion.
Fiera Capital is buying New York-based Samson Capital Advisors for about US$33.5 million.
U.S. drugstore retailer Rite Aid has agreed to purchase EnvisionRx, a pharmacy benefit management firm, for US$2 billion.
Great-West Lifeco Inc.'s European subsidiary, Canada Life Group, has reached an agreement to acquire Legal & General International (Ireland) Ltd. (LGII).
AstraZeneca has agreed to acquire the rights to Actavis’s branded respiratory business in Canada and the United States for US$600 million ($749 million).
Pfizer has agreed to buy Hospira for about US$17 billion ($21.3 billion) to boost its portfolio of injectable drugs and biosimilars.
The Ontario Teachers' Pension Plan has completed the acquisition of PODS, a provider of container-based moving and storage solutions.